[HTML][HTML] Efficacy of hemostatic matrix and microporous polysaccharide hemospheres
KM Lewis, H Atlee, A Mannone, L Lin… - journal of surgical …, 2015 - Elsevier
Abstract Background Microporous Polysaccharide Hemospheres (MPH) are a new plant-
derived polysaccharide powder hemostat. Previous studies investigated MPH as a …
derived polysaccharide powder hemostat. Previous studies investigated MPH as a …
An efficacy comparison of two hemostatic agents in a porcine liver bleeding model: gelatin/thrombin flowable matrix versus collagen/thrombin powder
Purpose: Management of bleeding during surgery can be aided by the application of topical
hemostatic agents. This study compared the hemostatic efficacy of a new powder agent …
hemostatic agents. This study compared the hemostatic efficacy of a new powder agent …
Observational evaluation of outcomes and resource utilization from hemostatic matrices in spine surgery
JS Price, S Tackett, V Patel - Journal of medical economics, 2015 - Taylor & Francis
Objective: Studies have indicated that outcomes may differ by choice of flowable hemostat,
but there is limited evidence in spine surgery. The objective of this study was to conduct a …
but there is limited evidence in spine surgery. The objective of this study was to conduct a …
Hemostatic efficacy of two topical adjunctive hemostats in a porcine spleen biopsy punch model of moderate bleeding
MH MacDonald, G Zhang, L Tasse, D Wang… - Journal of Materials …, 2021 - Springer
Topical hemostatic agents have become essential tools to aid in preventing excessive
bleeding in surgical or emergency settings and to mitigate the associated risks of serious …
bleeding in surgical or emergency settings and to mitigate the associated risks of serious …
[HTML][HTML] Real-world outcomes of hemostatic matrices in cardiac surgery
SM Tackett, D Calcaterra, G Magee… - Journal of cardiothoracic …, 2014 - Elsevier
Objective While hemostatic matrices are efficacious in achieving hemostasis, outcomes
research is limited; therefore, this study analyzed clinical outcomes of flowable hemostatic …
research is limited; therefore, this study analyzed clinical outcomes of flowable hemostatic …
Hemostatic efficacy of a flowable collagen-thrombin matrix during coronary artery bypass grafting: a double-blind randomized controlled trial
HH Kim, KJ Lee, DR Kang, JH Lee, YN Youn - Journal of Cardiothoracic …, 2023 - Springer
Background Flowable hemostatic agents have the advantage of being able to be applied to
irregular wound surfaces and difficult to reach areas. We sought to compare the …
irregular wound surfaces and difficult to reach areas. We sought to compare the …
A comparative analysis of collagen based dressings and polysaccharide microspheres for hemostasis management in hepatic stab wounds
FJ Sánchez del Valle, MI Sánchez-Seco… - Scientific Reports, 2025 - nature.com
This study aims to evaluate two of the most commonly used products, the collagen-based
patch (Hemopatch) and the micropolysaccharide microspheres powder (Perclot), in the …
patch (Hemopatch) and the micropolysaccharide microspheres powder (Perclot), in the …
Device for promotion of hemostasis and/or wound healing
K Larsen, M Sabra - US Patent 9,533,069, 2017 - Google Patents
First worldwide family litigation filed litigation Critical https://patents. darts-ip. com/? family=
40874873&utm_source= google_patent&utm_medium= platform_link&utm_campaign …
40874873&utm_source= google_patent&utm_medium= platform_link&utm_campaign …
Cost-consequence analysis of two different active flowable hemostatic matrices in spine surgery patients
D Makhija, M Rock, S Ikeme, E Kuntze… - Journal of medical …, 2017 - Taylor & Francis
Objectives: A recently published retrospective analysis comparing two different active
flowable hemostatic matrices (FLOSEAL and SURGIFLO Kit with Thrombin) showed …
flowable hemostatic matrices (FLOSEAL and SURGIFLO Kit with Thrombin) showed …
Syringe for mixing two components and for retaining a vacuum in a storage condition
K Larsen, LS Elle, TI Jensen - US Patent 10,918,796, 2021 - Google Patents
(57) ABSTRACT A syringe for mixing two substances which have been retained separately
inside the syringe is described, for instance in a storage condition. The syringe is used for 1) …
inside the syringe is described, for instance in a storage condition. The syringe is used for 1) …